Mode
Text Size
Log in / Sign up

Gut microbiota dysbiosis shows strong observational link to endometriosis in reproductive-aged womenGut bacteria linked to endometriosis, review finds

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret the link between gut dysbiosis and endometriosis as observational; causation remains unproven.

This narrative review explores the relationship between gut microbiota dysbiosis and endometriosis (EMs) in reproductive-aged women. The authors synthesize observational evidence suggesting a strong association between gut microbiota dysbiosis and EMs development. However, they emphasize that the exact pathogenesis is incompletely elucidated and that confounding factors and causal inference methodologies prevent establishing causation.

The review does not provide specific effect sizes, pooled analyses, or certainty ratings. It highlights current evidence levels without quantitative synthesis. No specific interventions, comparators, or outcomes are reported, and the sample size and follow-up duration are not described.

Limitations acknowledged include the observational nature of the evidence and the presence of confounding factors. The authors discuss methodological challenges in establishing causality. Safety and tolerability data are not reported.

For clinicians, this review underscores a potential link between gut microbiota and endometriosis but cautions against overinterpreting association as causation. Further research is needed to clarify mechanisms and clinical relevance.

A new review of existing research suggests that an imbalance in gut bacteria, known as dysbiosis, is strongly linked to endometriosis in women of reproductive age. The review looked at multiple studies and found a consistent pattern: women with endometriosis often have different gut bacteria compared to those without the condition.

However, the review is careful to point out that this is an association, not proof that gut bacteria cause endometriosis. The exact way endometriosis develops is still not fully understood, and there may be other factors at play. The researchers note that more work is needed to figure out if changing gut bacteria could help treat or prevent the disease.

This is a narrative review, which means it summarizes existing studies rather than presenting new data. It did not report on specific numbers of participants or safety concerns. The findings are interesting but early, and they don't change current medical advice for endometriosis.

For now, the main takeaway is that gut health may play a role in endometriosis, but we need more research to know for sure. If you have endometriosis, talk to your doctor about the best treatment options for you.

What this means for you:
Gut bacteria imbalance is linked to endometriosis, but more research is needed to confirm a cause.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Endometriosis (EMs) is a prevalent, estrogen-dependent gynecological disorder characterized by the ectopic implantation and proliferation of endometrial-like tissue outside the uterine cavity, affecting approximately 10% of reproductive-aged women globally. Despite its high incidence, the exact pathogenesis of EMs remains incompletely elucidated, and current clinical treatments are often limited by suboptimal efficacy and adverse effects. Accumulating evidence over the past decade has revealed a strong observational association between gut microbiota dysbiosis and EMs development, suggesting that the gut microbiota may serve as a novel potential target for understanding and managing this disease. This review systematically summarizes the potential mechanistic links underlying the interplay between gut microbiota dysbiosis and EMs progression, focusing on three core pathways: intestinal barrier dysfunction and microbial translocation, immune dysregulation and ectopic lesion immune escape, and estrogen metabolism disorder mediated by microbial enzymes and metabolites. In addition, this review stratifies gut microbiome profiles by EMs clinical subtypes (peritoneal, ovarian, deep infiltrating), clarifies anatomical correlations of the gut-lesion axis, and discusses confounding factors and causal inference methodologies. Beyond mechanistic insights, this review also discusses emerging gut microbiota-targeted therapeutic strategies for EMs, including probiotic supplementation, prebiotic intervention, fecal microbiota transplantation (FMT), and dietary modulation, with supplementary ethical considerations for FMT. Collectively, this review provides a comprehensive overview of the gut microbiota-EMs axis, highlighting current evidence levels and offering perspectives for the development of innovative, effective, and safe therapeutic approaches for EMs patients.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.